Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Long-term Investment Intensity
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Long-term Investment Intensity of 11.3% as of September 2019. Long-term investments of CN¥852.93 Million represent 11.3% of total assets of CN¥7.55 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of Tianjin Zhongxin Pharmaceutical Group Co to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 11.3%, reflecting long-term investments of CN¥852.93 Million against total assets of CN¥7.55 Billion CNY. Explore Tianjin Zhongxin Pharmaceutical Group Co (600329) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2015 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Tianjin Zhongxin Pharmaceutical Group Co market cap and net worth.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 10.9% | CN¥773.01 Million | CN¥7.11 Billion | ▼ -7.6 pp |
| 2016 | 18.5% | CN¥1.18 Billion | CN¥6.36 Billion | ▲ +4.7 pp |
| 2015 | 13.8% | CN¥835.72 Million | CN¥6.07 Billion | — |